Prof. Zhenggang Zhu 朱正纲
Oncology · Chief Physician, Professor
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Public profile Compiled from public sources. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionCurrent positions
- Tenured Professor of Surgery, Ruijin Hospital
Checked against a public report (检索 2026-11-15). Positions change; the hospital's website is the final word.
Clinical focus: Preoperative diagnosis and staging of gastrointestinal tumors; comprehensive surgical treatment of gastrointestinal tumors.
Conditions and procedures: Gastrointestinal tumors
From the doctor's own description on a public doctor-listing platform.
Name order: in Chinese the family name comes first (Zhu Zhenggang). Papers usually list the name as Zhenggang Zhu.
Selected publications
56 first- or senior-author papers on PubMed where the author's own affiliation is this hospital (51 since 2016), counted among the 200 most recent matching papers. Most recent:
- JAMA Oncol, 2026 (senior author): Concerns Regarding Patient Burden and Intraperitoneal Port Use in the DRAGON-01 Trial-Reply. PubMed 42690652
- JAMA Oncol, 2026 (senior author): Intraperitoneal and Intravenous Paclitaxel Plus S-1 for Gastric Cancer With Peritoneal Metastasis: A Phase 3 Randomized Clinical Trial. PubMed 42166134
- EClinicalMedicine, 2025 (senior author): Neoadjuvant FLOT versus SOX chemotherapy in locally advanced gastric cancer: secondary outcomes of a single-centre, open-label, randomised, exploratory phase 2 trial. PubMed 41181842
- Gastric Cancer, 2025 (first author): Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis. PubMed 40658310
- Healthcare (Basel), 2025 (senior author): Case Report: A Novel Reconstruction Method (Itihaas's Anastomosis) for Proximal Gastrectomy. PubMed 40724688
- J Clin Oncol, 2025 (senior author): Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05). PubMed 39383487
- Gastric Cancer, 2024 (senior author): Oncological outcomes of conversion therapy in gastric cancer patients with peritoneal metastasis: a large-scale retrospective cohort study. PubMed 38143257
- Ther Adv Med Oncol, 2024 (senior author): Analysis of circulating tumor DNA identifies distinct therapeutic response to intraperitoneal and intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis. PubMed 38249327
Each paper was checked automatically: the author listed with this name must give this hospital as their affiliation. See the full PubMed search.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and recommend a treatment plan.
Get a specialist opinion